277 followers
RT @FrontPharmacol: New Research: Dual inhibition of MEK and PI3Kβ/δ–a potential therapeutic strategy in PTEN-wild-type docetaxel-resistant…
RT @FrontPharmacol: New Research: Dual inhibition of MEK and PI3Kβ/δ–a potential therapeutic strategy in PTEN-wild-type docetaxel-resistant…
New Research: Dual inhibition of MEK and PI3Kβ/δ–a potential therapeutic strategy in PTEN-wild-type docetaxel-resistant metastatic prostate cancer https://t.co/nTgMqQkBRB #pharmacology
I'm excited to announce the publication of our article: "Dual Inhibition of MEK and PI3Kβ/δ – A Potential Therapeutic Strategy in PTEN-Wild-Type Docetaxel-Resistant Metastatic Prostate Cancer" in @FrontPharmacol. https://t.co/YVi5QQPO5g